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comorbidity in Illawarra Shoalhaven. Consistently higher burden of comorbidity was observed in some 
urban suburbs surrounding the major metropolitan city. Comparison of comorbidity hotspots with the 
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Abstract
Objectives
The primary aim of this study was to describe the geography of serious mental illness
(SMI)–type 2 diabetes comorbidity (T2D) in the Illawarra-Shoalhaven region of NSW, Aus-
tralia. The Secondary objective was to determine the geographic concordance if any,
between the comorbidity and the single diagnosis of SMI and diabetes.
Methods
Spatial analytical techniques were applied to clinical data to explore the above objectives.
The geographic variation in comorbidity was determined by Moran’s I at the global level and
the local clusters of significance were determined by Local Moran’s I and spatial scan statis-
tic. Choropleth hotspot maps and spatial scan statistics were generated to assess the geo-
graphic convergence of SMI, diabetes and their comorbidity. Additionally, we used bivariate
LISA (Local Indicators of Spatial Association) and multivariate spatial scan to identify coinci-
dent areas with higher rates of both SMI and T2D.
Results
The study identified significant geographic variation in the distribution of SMI–T2D comor-
bidity in Illawarra Shoalhaven. Consistently higher burden of comorbidity was observed in
some urban suburbs surrounding the major metropolitan city. Comparison of comorbidity
hotspots with the hotspots of single diagnosis SMI and T2D further revealed a geographic
concordance of high-risk areas again in the urban areas outside the major metropolitan city.
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Conclusion
The identified comorbidity hotspots in our study may serve as a basis for future prioritisation
and targeted interventions. Further investigation is required to determine whether contextual
environmental factors, such as neighbourhood socioeconomic disadvantage, may be
explanatory.
Implications for public health
Ours is the first study to explore the geographic variations in the distribution of SMI and T2D
comorbidity. Findings highlight the importance of considering the role of neighbourhood
environments in influencing the T2D risk in people with SMI.
Introduction
Research has established that type 2 diabetes (T2D) often co-occurs with serious mental ill-
ness (SMI) such as schizophrenia, bipolar disorder and major depression[1]. People with
SMI have 2–4 times higher risk of developing T2D compared with the general population,
which translates into an average reduction of 15–20 years in their life expectancies[2,3]. In
contrast, several lines of evidence also suggest that a diagnosis of T2D can increase the risk of
mental disorders such as depression[4]. For people with SMI, a comorbid diabetic diagnosis
not only confers a higher cardiovascular risk and increased risk of premature mortality,
but is also associated with greater cognitive decline, worse prognosis, increased hospitalisa-
tions, greater number of emergency department visits, non-adherence to treatments, higher
healthcare utilisation costs and decreased quality of life for people experiencing mentally ill-
health[3,5–9].
Significant geographic inequalities have been reported in the distribution of both severe
mental illness and T2D [10–18]. However, to the best of our knowledge, geographic varia-
tions in their comorbidity have not been previously explored. A recent systematic literature
review reported a paucity of research literature investigating the association between neigh-
bourhoods and SMI -T2D comorbidity[19]. Moreover, in recent years, there has been
increased interest in addressing comorbid conditions concurrently rather than as separate
diseases and an integrated management approach is now considered superior over a single
focus approach[20]. Exploring neighbourhood variations in the co-occurrence and cluster-
ing of SMI-T2D may help us to better understand the overlapping prevalence of these
two chronic diseases and to propose novel hypotheses regarding the neighbourhood level
factors that might influence the co-occurrence. Describing the geography may also
assist public health authorities to cost-effectively target local resources and preventive
interventions to reduce the regional disparities and public health burden imposed by the
comorbidity.
Accordingly, the purpose of this study was to examine the neighbourhood level geographic
variations in SMI-T2D comorbidity, in an Australian community using cross-sectional, rou-
tinely collected clinical data. We also aimed to determine the geographic concordance if any,
between the comorbidity and the single diagnosis of SMI and T2D.
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Research design and methods
Study area and population
This cross sectional study was carried out in the Illawarra and Shoalhaven regions of New
South Wales, Australia, which had an estimated resident population of 368,604 people at the
time of the 2011 Australian Census of Population and Housing[21]. Serious mental illness and
diabetes comorbidity data for the period of 2010 to 2017 were obtained from the Illawarra
Health Information Platform (IHIP), which is a research partnership established between Illa-
warra Shoalhaven Local Health District (ISLHD) and University of Wollongong for the pur-
pose of providing ISLHD health service data to researchers. Community-derived diabetes
data (without reference to comorbidities), were retrieved from the Southern IML Research
(SIMLR) study database for the period of 2010 to 2014. SIMLR is a longitudinal, community-
derived near-census database consisting of routinely collected pathology results for residents
18 years and over in Illawarra Shoalhaven[14]. All the data used in this study were deidentified
prior to extraction, consistent with the requirements of the Privacy Act 1988 (Cth) and Health
Records and Information Privacy Act 2002 (NSW). Residential suburbs were the smallest geo-
graphical units at which health service data were available and were used as the spatial units of
analysis. Information on the population of the region by age groups and gender was obtained
from the 2011 Australian Census of population and housing[21]. To display and analyse the
geographic distribution of SMI, T2D and their comorbidity, a base map of the Australian sub-
urbs 2011 digital boundaries from Australian Bureau of Statistics was used. This study was
approved by The University of Wollongong and Illawarra Shoalhaven Local Health District
Human Research Ethics Committee (protocol number 2017/428).
Study sample
Serious mental illness in our study was defined as a primary or secondary diagnosis of SMI
from the inpatient records of ISLHD. Data extraction was carried out by means of Interna-
tional Classification of Diseases (ICD) 10 codes (Table 1). Comorbidity was defined as having
a T2D stay diagnosis code (ICD code E11) in people with serious mental illness recorded in
the ISLHD data. Comorbidity details were extracted as either present or absent along with
each of the SMI records. The community-derived diabetes sample, consisted of individuals
with at least one HbA1c test between 2010 and 2014 and an HbA1c result� 6.5% or plasma
glucose levels�7.0mmol/L within 12 months of an HbA1c test, consistent with thresholds
used in the Australian National Health Measures Survey [22]. Data analysis was restricted to
individuals 18 years and over.
Statistical analysis
We calculated the relative risk of SMI-T2D comorbidity for each of the 167 suburbs in the Illa-
warra Shoalhaven region by computing the ratio of observed to the expected counts. The
Table 1. SMI diagnosis groups and ICD 10 codes included in the study.
Diagnosis ICD 10 codes
Schizophrenia F20
Other non-affective psychosis F22 –F29
Bipolar disorder F30, F31
Major depression F32, F33
Other affective disorders F34, F39
https://doi.org/10.1371/journal.pone.0225992.t001
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expected number of cases was calculated by indirect standardisation and was obtained by mul-
tiplying age-sex stratified population in each suburb by the age-sex stratified prevalence across
the entire study area. Expected counts for males and females aged 18–34, 35–49, 50–64 and
65+years were calculated separately and were then aggregated within suburbs to create an
aggregated denominator for the relative risk. Data over the entire study period (2010–2017)
were combined to ensure sufficient counts. The population profile of the study area had
remained relatively similar during these time period[21]. Suburbs with expected counts of zero
(n = 5) were merged with the neighbouring suburbs for further analysis. Large variance in rela-
tive risks was observed due to sparse comorbidity counts and the heterogeneous population
density in the area. To address this issue, relative risk data were smoothed using the Empirical
Bayes smoothing technique recommended by Anselin and Koschinsky to shrink and stabilise
the rates towards the global mean of the whole study region[23].
Global Moran’s I was used to investigate spatial autocorrelation or clustering in the raw
estimates[24]. Moran’s I statistic ranges between -1 and 1, with a value of zero indicating
complete spatial randomness; a positive value indicating positive spatial autocorrelation; and a
negative value indicating negative spatial autocorrelation[24]. Local Indicator of Spatial Asso-
ciation (LISA) and spatial scan statistics were used to identify the location of comorbidity clus-
ters. These two spatial analytical techniques were adopted simultaneously to complement the
findings and to provide more intuitive results [25]. LISA, often known as Local Moran’s I, was
used to detect the significant clusters of higher and lower relative risks of comorbidity[24].
High-high clusters are areas of significantly high rates surrounded by other areas of signifi-
cantly higher rates, and low-low clusters represents areas with lower risks surrounded by other
areas of lower values[26,27].
Spatial scan statistics works by imposing circular scanning windows of varying radii, which
gradually moves over the study area evaluating the likelihood ratios of all potential clusters
using a user defined maximum percentage of population at risk[28], which in this analysis was
set at a default maximum spatial cluster size of� 50%[29]. We employed a purely spatial retro-
spective scan using the discrete Poisson model, where by the number of events is assumed to
be Poisson distributed [28]. The input data for this model consisted of the observed and the
expected comorbidity counts. The ‘no geographic overlap’ criterion was used to report the
clusters and the p values calculated were two tailed.
In order to compare the geographic concordance of SMI-T2D comorbidity with the single
diagnosis of SMI and diabetes in the general population (Gen-DM), relative risk maps, LISA
maps and spatial scan statistics were generated for SMI and Gen-DM following the same pro-
cedures as the comorbidity map. Additionally, we used bivariate LISA[26,27] and multivariate
spatial scan[28] statistics to test the association between SMI and Gen-DM and to map their
associations at suburb level. The LISA bivariate statistic indicates how observations of a vari-
able (SMI) in a certain suburb are associated with the observations of a different variable
(Gen-DM) in the adjacent suburb. In our case, high-high clusters will indicate coincident
areas of high rates of SMI and Gen-DM and low-low clusters will be the areas of coincident
low rates of SMI and Gen-DM. Multivariate spatial scan identifies spatial clusters with higher
and lower rates for both SMI and Gen-DM by simultaneously searching for and evaluating
clusters within the two datasets. The likelihood ratio for each data set is summed up to deter-
mine the likelihood ratio for that particular window[28].
The statistical significance of Global Moran’s I, Local Moran’s I, Spatial scan and bivariate
LISA were evaluated under the complete spatial randomness assumptions using 9999 Monte
Carlo simulations and a significance level of 0.05[30]. Benjamini Hochberg correction was
applied to control for false discovery rates in LISA and Bivariate LISA statistics[31].
Exploring the geography of serious mental illness and type 2 diabetes comorbidity
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Software
We used Geo Da [27] for Empirical Bayes Smoothing and spatial analysis, SaTScan for univari-
ate and multivariate spatial scan statistics[28], R for descriptive analysis [32] and Arc GIS 10.5
for mapping[33].
Results
Sample description
A total of 4165 unduplicated records were extracted with an SMI diagnosis between 1 January
2010 and 31 December 2017. Individuals residing outside the Illawarra Shoalhaven area
(n = 50) and records with no suburb information (n = 283) were excluded from our analysis
(n = 341, 8.2%) resulting in a final SMI sample of 3824 people. Of these, 463 (12.1%) had a
T2D comorbidity. The community-derived diabetes sample for the region consisted of 13142
unique individuals. The distribution of SMI, diabetes and their comorbidity in the Illawarra
and Shoalhaven is described in Table 2. The median age of the comorbidity subgroup was 58
years (range = 18–92 years). The gender distribution was approximately equal with females
accounting for 52.9% of the sample. Higher comorbidity prevalence was observed in older
adults above 50 years of age.
Spatial distribution of SMI -T2D comorbidity
The geographic distribution of smoothed relative risks for SMI-T2D comorbidity in the Illa-
warra and Shoalhaven is depicted in Fig 1. Moran’s I revealed a positive global spatial autocor-
relation for SMI-T2D relative risk (Moran’s I = 0.1155, p = 0.0361) indicating that suburbs
with similar SMI- T2D risk are clustered geographically. Fig 2 demonstrates the results of the
application of LISA and spatial scan statistics to the SMI-T2D comorbidity risk by suburbs.
LISA analysis identified twelve (12) significant high-high clusters (hotspots) and four (4)
low-low clusters (cold spots), that became non-significant after correcting for multiple com-
parisons using the Benjamini–Hochberg FDR procedure. However, there was a strong corre-
spondence between uncorrected LISA and spatial scan analysis in identifying a hotspot
south of major metropolitan area as shown in Fig 2. The spatial scan statistics using a maxi-
mum cluster size of�50% of total population identified one significant high rate cluster of
Table 2. Distribution of serious mental illness, type 2 diabetes and their comorbidity in Illawarra Shoalhaven (2010–2017).
Demographic characteristics Serious mental illness Diabetes Serious mental illness -type 2 diabetes comorbidity
Total 3824 13142 463
Sex
Male
n (%)
1977 (51.7) 7248 (55.2) 218 (47.1)
Female
n (%)
1847 (48.3) 5894 (44.8) 245 (52.9)
Age (Years)
18–34
n (%)
1132 (29.6) 189 (1.4) 27 (5.8)
35–49
n (%)
1220 (31.8) 733 (5.6) 108 (23.3)
50–64
n (%)
820 (21.4) 3294 (25.1) 150 (32.4)
65+
n (%)
652 (17.1) 8926 (67.9) 178 (38.4)
https://doi.org/10.1371/journal.pone.0225992.t002
Exploring the geography of serious mental illness and type 2 diabetes comorbidity
PLOS ONE | https://doi.org/10.1371/journal.pone.0225992 December 5, 2019 5 / 13
SMI-T2D comorbidity in the suburbs south of major metropolitan city centre (Fig 2). The
high rate cluster identified comprised of 23 urban suburbs and had a relative risk of 1.80
(p <0.001). The number of observed comorbidity cases in this cluster was 110, compared to
68 expected cases. The identified high rate cluster contained 14.2% of the total population in
Fig 1. Smoothed relative risk of SMI-T2D comorbidity in the Illawarra Shoalhaven (2010–2017).
https://doi.org/10.1371/journal.pone.0225992.g001
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the Illawarra Shoalhaven. No significant low rate clusters were detected by spatial scan. Six
urban suburbs south of major metropolitan city were identified as high-risk areas for
SMI-T2D comorbidity as they consistently appeared in both LISA and spatial scan statistics
as a high rate cluster.
Fig 2. Local Moran’s I and spatial scan statistics calculated for SMI-T2D comorbidity in Illawarra—Shoalhaven
(2010–2017).
https://doi.org/10.1371/journal.pone.0225992.g002
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Geographic concordance of SMI, T2D and their comorbidity
In order to compare the geographic concordance of SMI-T2D comorbidity with the SMI and
diabetes risk in Illawarra Shoalhaven, smoothed relative risk maps, LISA maps and spatial scan
statistics were generated for SMI, Gen-DM and SMI-T2D comorbidity (Fig 3). For SMI, we
identified 6 high-high clusters, 10 low-low clusters, 4 low-high clusters and 8 high-low clusters.
For Gen-DM the high-high, low-low, low-high and high-low clusters identified were 6, 12, 2
and 5 respectively. Both LISA and spatial scan statistics (Table 3) consistently identified a con-
vergence of hotspots (high-high clusters) for SMI, T2D and their comorbidity in four urban
suburbs south of the major metropolitan centre, which was previously identified as a comor-
bidity hotspot.
Fig 4 shows the result of bivariate LISA analysis and multivariate spatial scan for SMI and
diabetes in Illawarra and Shoalhaven. Five high-high clusters indicating suburbs of higher
SMI risk surrounded by neighbourhoods of higher diabetes risk were observed in the south-
ern urban areas. The analysis also revealed 7 low-low clusters in the central part of study
region. Similar to LISA clusters, application of multiple comparison correction to these
results didn’t yield any significant results. Multivariate spatial scan analysis with a maxi-
mum spatial cluster size of up to 50% identified one high rate cluster for both SMI and
Gen-DM comprising of 4 suburbs with a relative risk of 1.63 (log likelihood ratio 178.8,
p <0.001).
Fig 3. Geographic distribution and significant hotspots for SMI, diabetes and SMI -T2D comorbidity in Illawarra—Shoalhaven
(2010–2017).
https://doi.org/10.1371/journal.pone.0225992.g003
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Discussion
The present study identified geographic variations in the distribution of SMI–T2D comorbid-
ity in the Illawarra Shoalhaven. The spatial dependence of comorbidity was confirmed by the
global test for spatial autocorrelation (Moran’s I). In other words, suburbs with higher comor-
bidity risk tend to locate closer than we would expect at random. Conversely, suburbs with
lower comorbidity risk also tend to cluster together geographically. Using local indicators of
spatial association (LISA and spatial scan statistics), we were able to identify a consistently
higher burden of comorbidity in Six urban suburbs south of the metropolitan city. These sub-
urbs are relatively homogeneous in terms of their population density and socioeconomic envi-
ronments. Comparison of comorbidity hotspots with the hotspots of single diagnosis SMI and
diabetes further revealed a geographic concordance of high-risk areas in four urban regions of
the main metropolitan. These findings suggest that the population in some urban suburbs are
challenged by SMI, T2D and their comorbidity and appropriate prevention and management
initiatives should be targeted accordingly. This study has also demonstrated the potential use-
fulness of combining spatial analytical methods and clinical data information to inform health
service commissioning and geographically target needs-based preventive interventions.
We observed that both LISA and bivariate LISA clusters became non-significant after cor-
recting for multiple comparisons using Benjamini Hochberg procedure. Even though Benja-
mini–Hochberg correction is a less conservative method compared to other false discovery
correction procedures, there can still be substantial loss of power (constraining the type I error
rate at the expense of an increasing type II error rate) when dealing with bigger datasets [31].
This loss of power could have contributed to our null results. Despite this potential limitation,
the correspondence between uncorrected LISA and spatial scan analyses in identifying hot-
spots south of the major metropolitan area indicate that our results remain interesting. This is
the first study to explore the geographic variations in the distribution of SMI and T2D comor-
bidity. Lack of evidence in this important area of public health was highlighted in a recent
systematic literature review[19]. Previous research has, however, established significant geo-
graphic inequalities and urban clustering in the distribution of both SMI and type 2 diabetes
[13–18]. In this study, we were able to demonstrate that this relationship holds true for their
comorbidity as well. From a health service research and policy perspective, describing the
geography of coexisting diseases together might prove more useful in aiding decisions on the
allocation of resources and integrated interventions. Findings from this study will also create
opportunities for further exploratory hypothesis testing, using spatial clustering as a frame-
work. One commonly hypothesised and plausible contributory exposure is neighbourhood
Table 3. Significant spatial scan clusters of SMI, diabetes (general population) and SMI—T2D comorbidity (Illawarra -Shoalhaven 2010–2017).
Diagnosis Cluster Type No of suburbs Observed count Expected Count Relative risk Log likelihood P value
SMI High 24 1350 1056.13 1.43 53.54 <0.001
High 12 222 152.37 1.49 14.58 <0.001
Low 16 248 404.99 0.59 38.89 <0.001
Low 3 1 26.21 0.038 22.02 <0.001
Low 5 31 60.43 0.094 14.53 <0.001
SMI-T2D comorbidity High 23 163 102.97 1.89 20.02 <0.001
Gen-DM High 4 917 577.09 1.63 89.40 <0.001
High 5 1157 967.84 1.21 18.86 <0.001
Low 14 1076 1555.69 0.66 92.80 <0.001
Low 12 570 732.79 0.77 20.65 <0.001
https://doi.org/10.1371/journal.pone.0225992.t003
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socioeconomic disadvantage. Disadvantaged neighbourhoods often expose mentally ill
persons to greater psychosocial stress, or act as a proxy for adverse health behaviours such
as unhealthy eating, lack of physical activity and obesity, which have been shown to be associ-
ated with increased T2D risk[17,34,35]. Thus, identification and exploration of these
Fig 4. Bivariate LISA and multivariate spatial scan clusters showing the local association between SMI and
diabetes in Illawarra and Shoalhaven (2010–2017).
https://doi.org/10.1371/journal.pone.0225992.g004
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neighbourhood features that might influence SMI -T2D comorbidity will be an important
next step for enhancing our understanding of the geography of comorbidity and will be
addressed in future research.
The overall aim of our study was to generate information that could be useful to guide
health service policies and preventive interventions aimed at reducing the burden of T2D
comorbidity in people with serious mental illness. We have identified hotspots of SMI, T2D
and their comorbidity in some urban regions of the Illawarra–Shoalhaven. Targeted health
care strategies focussed on these regions may possibly reduce the health inequality and public
health burden imposed by SMI–T2D comorbidity.
The results from this study should be interpreted with respect to their limitations. Firstly,
the serious mental illness and comorbidity data were sourced only from inpatient mental
health records of ISLHD and did not consider outpatient and private practice records. Even
though this is supported by the data from the Australian National Surveys of Psychosis (indi-
cating that 45.6–62.9% of people with SMI reported�1 hospital admission for any reason in
the previous 12 months)[36], the results from our study cannot be applied to the general popu-
lation. The second limitation is the cross-sectional study design that does not permit cause and
effect conclusions. We also note that there’s a potential for temporal misalignment as 2011
census data was used as the reference population. However, a sensitivity analysis using 2016
census data did not alter the results significantly.
Conclusions
In this study we combined spatial analytical methods and clinical data to analyse the spatial
distribution of SMI -T2D comorbidity in Illawarra Shoalhaven. Our results revealed evidence
of spatial variations in the distribution of SMI -T2D comorbidity. The high-risk clusters were
mainly located in the urban areas. The findings from this study emphasise the geographic
focus needed in these regions to reduce the T2D burden in SMI. This study has also demon-
strated the potential of spatial analytical methods in assessing and identifying spatial disparities
in the comorbid disease risks so that preventive interventions and resources are appropriately
targeted. Further investigation using multilevel analytical techniques is required to determine
whether particular environmental factors such as neighbourhood socioeconomic disadvantage
may be explanatory for these geographic variations in SMI -T2D comorbidity. Understanding
the neighbourhood correlates will help us in developing evidence based holistic interventions,
health care policies and potentially the design of healthier places to live.
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